Accession: MTBLS4063
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase; Liquid Chromatography MS - positive
Organism: unspec
Size (indexed): 73.6 GB (79012251849 bytes)
Downloaded bytes: 2.9 MB (3082573 bytes)
Access / raw: public / OPEN-raw
Download
- Source URL: https://ftp.ebi.ac.uk/pub/databases/metabolights/studies/public/MTBLS4063/
- PMIDs: 36206710, |, DOI:10.1016/j.jhazmat.2022.130083
Files
| File | Size | SHA256 |
|---|---|---|
MTBLS4063.announcement.json | 190.7 KB | 6ba1e33d74de848d… |
MTBLS4063.mhd.json | 2.2 MB | e42af9fdab82e584… |
a_MTBLS4063_LC-MS_HepaRG_dose_cells_NEG.txt | 9.0 KB | d77c9209e9c932b7… |
a_MTBLS4063_LC-MS_HepaRG_dose_cells_POS.txt | 9.0 KB | fed53db5980ebf74… |
a_MTBLS4063_LC-MS_HepaRG_dose_medium_NEG.txt | 11.3 KB | 9b4ab007ab29c0dc… |
a_MTBLS4063_LC-MS_HepaRG_dose_medium_POS.txt | 11.3 KB | 646cc2fb5546d580… |
a_MTBLS4063_LC-MS_HepaRG_kinetic_cells_NEG.txt | 18.3 KB | 751f9d5db1fb3c68… |
a_MTBLS4063_LC-MS_HepaRG_kinetic_cells_POS.txt | 18.3 KB | 5ffc71865129152a… |
a_MTBLS4063_LC-MS_HepaRG_kinetic_medium_NEG.txt | 17.4 KB | ad721f79c2c2b4d4… |
a_MTBLS4063_LC-MS_HepaRG_kinetic_medium_POS.txt | 17.4 KB | 7770de9a68fefdc0… |
a_MTBLS4063_LC-MS_Human_PHH_dose_cells_NEG.txt | 5.5 KB | 93292ab14e7f76a6… |
a_MTBLS4063_LC-MS_Human_PHH_dose_cells_POS.txt | 6.1 KB | d1d2285ec176550b… |
a_MTBLS4063_LC-MS_Human_PHH_dose_medium_NEG.txt | 6.1 KB | f5c5a6a65624d534… |
a_MTBLS4063_LC-MS_Human_PHH_dose_medium_POS.txt | 6.1 KB | e06143cfade23912… |
a_MTBLS4063_LC-MS_Rat_PRH_dose_cells_NEG.txt | 5.9 KB | 43f4a29bb02235eb… |
a_MTBLS4063_LC-MS_Rat_PRH_dose_cells_POS.txt | 5.9 KB | f10f31baf9924f56… |
a_MTBLS4063_LC-MS_Rat_PRH_dose_medium_NEG.txt | 6.0 KB | 190ab22dd36314e2… |
a_MTBLS4063_LC-MS_Rat_PRH_dose_medium_POS.txt | 6.0 KB | 615a90832642aef4… |
i_Investigation.txt | 18.5 KB | cf50e5e6dd8fab3a… |
m_MTBLS4063_LC-MS_HepaRG_dose_cells_NEG_v2_maf.tsv | 40.7 KB | 981efac6b7e02f6f… |
m_MTBLS4063_LC-MS_HepaRG_dose_cells_POS_v2_maf.tsv | 54.6 KB | 0830716bdda74c21… |
m_MTBLS4063_LC-MS_HepaRG_dose_medium_NEG_v2_maf.tsv | 14.3 KB | f92ad01fdfc91968… |
m_MTBLS4063_LC-MS_HepaRG_dose_medium_POS_v2_maf.tsv | 11.3 KB | 6bf9e57fab4db9fd… |
m_MTBLS4063_LC-MS_HepaRG_kinetic_cells_NEG_v2_maf.tsv | 24.1 KB | 4e56800c1f97085e… |
m_MTBLS4063_LC-MS_HepaRG_kinetic_cells_POS_v2_maf.tsv | 16.7 KB | cda035c7b8e2b854… |
m_MTBLS4063_LC-MS_HepaRG_kinetic_medium_NEG_v2_maf.tsv | 48.6 KB | 2f6a7720bda909ca… |
m_MTBLS4063_LC-MS_HepaRG_kinetic_medium_POS_v2_maf.tsv | 46.4 KB | 2fc6cd713c461db8… |
m_MTBLS4063_LC-MS_Human_PHH_dose_cells_NEG_v2_maf.tsv | 3.8 KB | d26aed29d9581c64… |
m_MTBLS4063_LC-MS_Human_PHH_dose_cells_POS_v2_maf.tsv | 10.4 KB | 4adf12c2d1900f1e… |
m_MTBLS4063_LC-MS_Human_PHH_dose_medium_NEG_v2_maf.tsv | 19.4 KB | bdd4e179345c6842… |
m_MTBLS4063_LC-MS_Human_PHH_dose_medium_POS_v2_maf.tsv | 26.7 KB | 19d1c0483dd6dd98… |
m_MTBLS4063_LC-MS_Rat_PRH_dose_cells_NEG_v2_maf.tsv | 2.9 KB | 090e00402f05da85… |
m_MTBLS4063_LC-MS_Rat_PRH_dose_cells_POS_v2_maf.tsv | 19.0 KB | 0edd61a088ac8b3b… |
m_MTBLS4063_LC-MS_Rat_PRH_dose_medium_NEG_v2_maf.tsv | 3.1 KB | 1ddef546f2294f08… |
m_MTBLS4063_LC-MS_Rat_PRH_dose_medium_POS_v2_maf.tsv | 10.9 KB | cc4555cbda7ff40f… |
s_MTBLS4063.txt | 53.8 KB | 82ebcb1222ce561e… |
Index note: public study (ISA-Tab+MAF)
Crawled by masld-atlas-crawler v1.0 at 2026-08-02T22:16:08Z.
About this dataset
This metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase; Liquid Chromatography MS - positive dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.
Analyze it in Drylab
Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:
- Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
- Normalize, select variable genes, then cluster the cells and draw a UMAP.
- Annotate clusters with marker genes and compare the cell-type mix between conditions.
- Run differential expression between cell types or samples to characterize masld/nafld/nash biology.